These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24450424)

  • 1. Enzymatic formation of PEGylated oligonucleotides.
    Sosic A; Pasqualin M; Pasut G; Gatto B
    Bioconjug Chem; 2014 Feb; 25(2):433-41. PubMed ID: 24450424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic oligonucleotides with polyethylene glycol modifications.
    Winkler J
    Future Med Chem; 2015; 7(13):1721-31. PubMed ID: 26465713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity hydrogels for controlled protein release using nucleic acid aptamers and complementary oligonucleotides.
    Soontornworajit B; Zhou J; Snipes MP; Battig MR; Wang Y
    Biomaterials; 2011 Oct; 32(28):6839-49. PubMed ID: 21684002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PEG Architecture on the Hybridization Thermodynamics and Protein Accessibility of PEGylated Oligonucleotides.
    Jia F; Lu X; Tan X; Wang D; Cao X; Zhang K
    Angew Chem Int Ed Engl; 2017 Jan; 56(5):1239-1243. PubMed ID: 28032948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of polyethylenimines and polyethylenimine-graft-poly (ethylene glycol) block copolymers to protect oligonucleotides against enzymatic degradation.
    Brus C; Petersen H; Aigner A; Czubayko F; Kissel T
    Eur J Pharm Biopharm; 2004 May; 57(3):427-30. PubMed ID: 15093589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer PEG-enzymes: 30 years old, but still a current approach.
    Pasut G; Sergi M; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):69-78. PubMed ID: 17869378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and biological characterization of polyethylenimine-graft-poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes.
    Brus C; Petersen H; Aigner A; Czubayko F; Kissel T
    Bioconjug Chem; 2004; 15(4):677-84. PubMed ID: 15264853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic Synthesis of Backbone-Modified Oligonucleotides Using T4 DNA Ligase.
    Kestemont D; Herdewijn P; Renders M
    Curr Protoc Chem Biol; 2019 Jun; 11(2):e62. PubMed ID: 30688416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new platform for oligonucleotide delivery utilizing the PEG prodrug approach.
    Zhao H; Greenwald RB; Reddy P; Xia J; Peng P
    Bioconjug Chem; 2005; 16(4):758-66. PubMed ID: 16029016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-nucleotide-specific PNA-peptide ligation on synthetic and PCR DNA templates.
    Ficht S; Mattes A; Seitz O
    J Am Chem Soc; 2004 Aug; 126(32):9970-81. PubMed ID: 15303871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of oligonucleotides against nucleases by pegylated and non-pegylated liposomes as studied by fluorescence correlation spectroscopy.
    Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
    J Control Release; 2005 Dec; 110(1):212-26. PubMed ID: 16298008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
    Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembly of stable monomolecular nucleic acid lipid particles with a size of 30 nm.
    Rudorf S; Rädler JO
    J Am Chem Soc; 2012 Jul; 134(28):11652-8. PubMed ID: 22694262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of oligonucleotide derivatives using ChemMatrix supports.
    Mazzini S; García-Martin F; Alvira M; Aviñó A; Manning B; Albericio F; Eritja R
    Chem Biodivers; 2008 Jan; 5(1):209-18. PubMed ID: 18205124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides.
    Bonora GM; Ivanova E; Zarytova V; Burcovich B; Veronese FM
    Bioconjug Chem; 1997; 8(6):793-7. PubMed ID: 9404651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytocompatibility and Cellular Internalization of PEGylated "Clickable" Nucleic Acid Oligomers.
    Anderson AJ; Peters EB; Neumann A; Wagner J; Fairbanks B; Bryant SJ; Bowman CN
    Biomacromolecules; 2018 Jul; 19(7):2535-2541. PubMed ID: 29698604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glass surfaces grafted with high-density poly(ethylene glycol) as substrates for DNA oligonucleotide microarrays.
    Schlapak R; Pammer P; Armitage D; Zhu R; Hinterdorfer P; Vaupel M; Frühwirth T; Howorka S
    Langmuir; 2006 Jan; 22(1):277-85. PubMed ID: 16378432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Enzymatic Stability and the Pharmacokinetics of Oligonucleotides via DNA-Backboned Bottlebrush Polymers.
    Jia F; Wang D; Lu X; Tan X; Wang Y; Lu H; Zhang K
    Nano Lett; 2018 Nov; 18(11):7378-7382. PubMed ID: 30376347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemical reactions in double-stranded nucleic acids. The nature of the bond formed during chemical ligation using a cis-diol group].
    Kuznetsova SA; Ivanovskaia MG; Shabarova ZA
    Bioorg Khim; 1987 Aug; 13(8):1139-41. PubMed ID: 3675653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.